Social Media Influencers Fueling Unofficial Trade for Unapproved Weight-Loss Drug
An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source.
Several experts said the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the service has removed problematic material and banned related keywords and search suggestions. The organization said it was committed to keeping the service secure and investing in strengthening enforcement strategies.
Online Marketplace Activities
Research also discovered communities with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of weight loss, positive testimonials and step-by-step instructions for mixing or administering at home.
Within minutes of joining one group, a vendor posted WhatsApp details, where most transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.
Item Details and Costs
Within these groups, posts show dark colored parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram stated it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.
Her team has previously seen patients harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to possibly significant health risks”.
